Jessica Nye

Barcelona

Postdoc at CRAG @UABBarcelona. Focused on evolution and population genetics with a sprinkling of computer vision methodology.

Articles

Women Less Likely to Receive Guideline-Recommended Medications Following Stroke

4 days ago | thecardiologyadvisor.com | Jessica Nye

After stroke, men and women receive differing poststroke prevention medications, according to results of a study published in Stroke. Previous studies have found that women were less likely to receive hyperacute therapies, early mobilization interventions, and secondary preventative medications than men after stroke.
Insulin Resistance Indicators May Predict Infertility Among Women

4 days ago | endocrinologyadvisor.com | Jessica Nye

Four insulin resistance indicators are associated with infertility among women of reproductive age, according to results of a study published in Reproductive Biology and Endocrinology. Infertility rates have continued to increase in recent years, with lifestyle factors possibly contributing to this trend. Investigators from Ningxia Medical University in China conducted a cross-sectional study with data from the National Health and Nutrition Examination Survey (NHANES).
Ropeginterferon Outperforms Anagrelide as Second-Line Treatment in High-Risk ET

5 days ago | hematologyadvisor.com | Jessica Nye

Ropeginterferon alfa-2b proved more effective than anagrelide in a phase 3 trial of patients with high-risk essential thrombocythemia (ET) who were resistant or intolerant to hydroxyurea. Results from this trial were presented at the EHA 2025 Congress. The trial, SURPASS-ET (NCT04285086), included 174 patients with high-risk ET who were resistant or intolerant to hydroxyurea. The patients were randomly assigned to receive either ropeginterferon alfa-2b (n=91) or anagrelide (n=83) for 52 weeks.
Do Questionnaires and Bowel Diaries Capture the Same Constipation Profile?

5 days ago | gastroenterologyadvisor.com | Jessica Nye

Diaries provide a more accurate record of bowel habits among individuals with constipation, compared with questionnaires. Somatic vs bowel symptoms also contribute more to a decreased quality of life (QOL). Combined, these findings could help better inform clinical trials, epidemiological studies, and clinical practice, according to study results published in Clinical Gastroenterology and Hepatology.
Preeclampsia Increases Risk for Myocardial Infarction Later in Life

5 days ago | endocrinologyadvisor.com | Jessica Nye

Risk for myocardial infarction (MI) and worse MI outcomes are higher among patients with history of preeclampsia. These findings were published in Circulation: Cardiovascular Quality and Outcomes. Patients who have hypertensive disorders of pregnancy are at higher risk for lifetime cardiovascular disease (CVD). However, the relationship between preeclampsia and MI is poorly understood.
Early Menopause Could Affect Female Offspring Risk for Prediabetes

5 days ago | endocrinologyadvisor.com | Jessica Nye

Early maternal menopause is associated with risk for prediabetes in early adulthood among daughters, according to results of a prospective, population-based study, published in Reproductive Biology and Endocrinology. Early menopause is defined as cessation of menstruation before 45 years of age. However, no existing data supports an effect of early menopausal age on cardiometabolic risk among offspring.
Subcutaneous Infliximab Outperforms Combination Therapy for IBD

5 days ago | rheumatologyadvisor.com | Jessica Nye

Immunogenicity is more prevalent among individuals who receive subcutaneous (SC) infliximab vs intravenous (IV) infliximab with an immunomodulator combined, according to study results published in Clinical Gastroenterology and Hepatology. Data about whether IV combinatorial or IV infliximab monotherapy is associated with decreased risk for immunogenicity have been conflicting. In addition, an SC infliximab formulation is now available.
Clinician’s Suicide Risk Assessment More Accurate in Outpatient Setting

5 days ago | ophthalmologyadvisor.com | Jessica Nye

Clinicians had a more accurate suicide risk assessment in the outpatient setting than in the inpatient or emergency department (ED) setting, according to results of a study published in JAMA Psychiatry. It remains unclear how accurate, or clinically useful, a clinician’s assessment of suicide risk is in a real-world setting. To that aim, the current study aimed to categorize clinician risk stratification and examine the overall predictive accuracy of suicide risk assessment (SRA).
Tafasitamab Combo May Be New Standard for Rel/Ref Follicular Lymphoma

5 days ago | shorturl.at | Jessica Nye

Adding tafasitamab to treatment with lenalidomide and rituximab can improve responses and progression-free survival (PFS) in patients with relapsed or refractory follicular lymphoma (FL), according to research presented at the 18th International Conference on Malignant Lymphoma.1 These results, from the phase 3 inMIND trial, suggest that tafasitamab plus lenalidomide and rituximab may represent a new standard of care for this patient population, said study presenter Laurie H.
Eptinezumab Benefit for Chronic Migraine Linked to Patient-Reported Good Days

5 days ago | neurologyadvisor.com | Jessica Nye

An improvement of at least 75% in self-rated good days per month serves as a comprehensive and effective outcome for assessing antimigraine medication efficacy in chronic migraine, according to study results presented at the 2025 American Headache Society (AHS) Annual Scientific Meeting, held from June 19-22, in Minneapolis, Minnesota, and virtually. The traditional threshold for response to migraine treatment has been a 50% or greater reduction in average monthly migraine days.